The use of isobaric tag peptide labeling (iTRAQ) and mass spectrometry to examine rare, primitive hematopoietic cells from patients with chronic myeloid leukemia

doi:10.1007/s12033-007-0005-5

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

The use of isobaric tag peptide labeling (iTRAQ) and mass spectrometry to examine rare, primitive hematopoietic cells from patients with chronic myeloid leukemia

19 Apr 2007

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Chronic Myeloid Leukemia Treatments
Share to Eosinophilic Disorders and Syndromes
Share to PI3K/AKT/mTOR signaling in cancer

Source

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Open in PubMed

Identifiers

PMID: 17914187
DOI: 10.1007/s12033-007-0005-5

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 8 closest

The use of isobaric tag peptide labeling (iTRAQ) and mass spectrometry to examine rare, primitive hematopoietic cells from patients with chronic myeloid leukemiaPMID 17914187Read ↗

Proteomic analysis of hematopoietic stem cell-like fractions in leukemic disordersSemantic proximity Read ↗

Proteomic approaches in myeloid leukemia.Semantic proximity Read ↗

Protein profiles distinguish stable and progressive chronic lymphocytic leukemia.Semantic proximity Read ↗

Identification of Neural Stem Cell Biomarkers by Isobaric Tagging for Relative and Absolute Quantitation (iTRAQ) Mass Spectrometry.Semantic proximity Read ↗

Novel Antigen Targets for Immunotherapy of Acute Myeloid Leukemia.Semantic proximity Read ↗

Quantitative protein expression analysis of CLL B cells from mutated and unmutated IgV(H) subgroups using acid-cleavable isotope-coded affinity tag reagents.Semantic proximity Read ↗

The Past, Present and Future Subclassification of Patients with Acute Myeloid Leukemia.Semantic proximity Read ↗

[Molecular pathophysiology and diagnosis of acute myeloid leukemia].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.